Malignant pheochromocytoma

被引：35

作者：

Mundschenk, J ^{[1
]}

Lehnert, H ^{[1
]}

机构：

[1] Univ Hosp Magdeburg, Dept Endocrinol & Metab, Magdeburg, Germany

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 1998年 / 106卷 / 05期

关键词：

malignant pheochromocytoma; somatostatin; octreotide; MIBG-therapy;

D O I：

10.1055/s-0029-1212001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：373 / 376

页数：4

共 27 条

[1] MALIGNANT PHEOCHROMOCYTOMA - EFFECTIVE TREATMENT WITH A COMBINATION OF CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE [J].

AVERBUCH, SD ;

STEAKLEY, CS ;

YOUNG, RC ;

GELMANN, EP ;

GOLDSTEIN, DS ;

STULL, R ;

KEISER, HR .

ANNALS OF INTERNAL MEDICINE, 1988, 109 (04) :267-273

[2]

BOLLAND GW, 1995, CRIT REV DIAGN IMAG, V36, P115

[3] EVOLVING CONCEPTS IN THE PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT OF PHEOCHROMOCYTOMA [J].

BRAVO, EL .

ENDOCRINE REVIEWS, 1994, 15 (03) :356-368

[4] MOLECULAR AND PHARMACOLOGICAL CHARACTERIZATION OF SOMATOSTATIN RECEPTOR SUBTYPES IN ADRENAL, EXTRAADRENAL, AND MALIGNANT PHEOCHROMOCYTOMAS [J].

EPELBAUM, J ;

BERTHERAT, J ;

PREVOST, G ;

KORDON, C ;

MEYERHOF, W ;

WULFSEN, I ;

RICHTER, D ;

PLOUIN, PF .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (06) :1837-1844

[5]

GROUZMANN E, 1990, CANCER, V66, P1833, DOI 10.1002/1097-0142(19901015)66:8<1833::AID-CNCR2820660831>3.0.CO

[6]

2-9

[7]

HOEFNAGEL CA, 1994, EUR J NUCL MED, V21, P561

[8] EFFECT OF OCTREOTIDE ON CATECHOLAMINE PLASMA-LEVELS IN PATIENTS WITH CHROMAFFIN CELL TUMORS [J].

INVITTI, C ;

DEMARTIN, M ;

BOLLA, GB ;

GIRALDI, FP ;

MAESTRI, E ;

LEONETTI, G ;

CAVAGNINI, F .

HORMONE RESEARCH, 1993, 40 (04) :156-160

[9]

ISOBE K, IN PRESS EUR J ENDOC

[10] LONG-TERM MANAGEMENT OF THE CARCINOID-SYNDROME - TREATMENT WITH OCTREOTIDE ALONE AND IN COMBINATION WITH ALPHA-INTERFERON [J].

JANSON, ET ;

OBERG, K .

ACTA ONCOLOGICA, 1993, 32 (02) :225-229

← 1 2 3 →